Skip to main content

Oncolys BioPharma, Inc.

  • | Biotech or pharma, therapeutic R&D
Oncolys BioPharma, Inc.
Oncolys BioPharma is a public clinical-stage company developing oncolytic viruses. OBP-301 is the first-in-class oncolytic adenovirus for Esophageal Cancer. We are also developing HDAC inhibitor and small molecule anti-SARS-Cov-2, and cancer diagnostic

Address

Tokyo
Tokyo
Japan
Visit website

Contact Exhibitor


Loading
View all Exhibitors
Testimonials

Double Helix


 

Supporting Bank Sponsor


 

Premier Sponsors

Conference Sponsors